ArticleeNeurologicalSci2019
Atezolizumab-induced encephalitis in metastatic lung cancer: a case report and literature review.
Article in eNeurologicalSci, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 25 citations in OpenAlex.
- Atezolizumab Immunotherapy-Induced Encephalitis in a Patient With Triple-Negative Breast Cancer: A Case Report.Cureus · 2025Article
- Patient with Atezolizumab-induced Encephalitis in Hepatocellular Carcinoma.Internal medicine (Tokyo, Japan) · 2025Article
- Clinical characteristics, diagnosis, treatment, and prognosis of Atezolizumab-induced encephalitis, aseptic meningitis or meningoencephalitis.Frontiers in human neuroscience · 2025Review
- Liver Cancer with Overlapping Myasthenia Gravis, Myocarditis, Seronegative Autoimmune Autonomic Ganglionopathy, and Myositis Symptoms Induced by Atezolizumab.Internal medicine (Tokyo, Japan) · 2024Article
- Immune Checkpoint Inhibitor-Associated Striatal Encephalitis Presenting with Subacute Progressive Parkinsonism.Movement disorders clinical practice · 2023Article
- Long-term complete remission after severe pembrolizumab-induced immune-related encephalitis in metastatic lung adeno-squamous carcinoma: A case report.Respiratory medicine case reports · 2023Article
- Atezolizumab-induced Encephalitis in a Patient with Hepatocellular Carcinoma: A Case Report and Literature Review.Internal medicine (Tokyo, Japan) · 2022Review
- Atezolizumab-associated encephalitis in metastatic breast cancer: A case report.Oncology letters · 2022Article
- Pembrolizumab-Induced Meningoencephalitis: A Brain Autopsy Case.Journal of medical cases · 2021Article
- Atezolizumab-induced encephalitis in a patient with metastatic breast cancer: a case report and review of neurological adverse events associated with checkpoint inhibitors.Autopsy & case reports · 2021Article
- Case Report: Durvalumab-Associated Encephalitis in Extensive-Stage Small Cell Lung Carcinoma.Frontiers in oncology · 2021Article
- Early-onset meningitis associated with atezolizumab treatment for non-small cell lung cancer: case report and literature review.Investigational new drugs · 2020Review
- Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report.Journal of medical case reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.